DermTech (DMTKQ)
(Delayed Data from OTC)
$0.01 USD
+0.01 (104.29%)
Updated Aug 16, 2024 03:55 PM ET
3-Hold of 5 3
C Value C Growth A Momentum B VGM
Cash flow Statements
Fiscal Year End for DermTech, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -100.89 | -116.68 | -78.34 | -35.25 | -19.69 |
Depreciation/Amortization & Depletion | 5.32 | 4.86 | 3.05 | 0.49 | 2.07 |
Net Change from Assets/Liabilities | 0.01 | -2.56 | -1.20 | 1.12 | 0.66 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 18.58 | 19.12 | 14.38 | 4.96 | -0.84 |
Net Cash From Operating Activities | -76.98 | -95.26 | -62.11 | -28.68 | -17.79 |
Property & Equipment | -0.90 | -3.31 | -2.72 | -1.83 | -0.21 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 30.77 | -1.01 | -9.79 | -39.51 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 29.86 | -4.32 | -12.51 | -41.34 | -0.21 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 6.19 | 1.05 | 230.45 | 80.35 | 24.74 |
Issuance (Repayment) of Debt | -0.11 | -0.14 | -0.17 | 0.00 | 2.60 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | -1.45 | 1.29 |
Net Cash from Financing Activities | 6.08 | 0.92 | 230.28 | 78.90 | 28.62 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -41.04 | -98.66 | 155.66 | 8.87 | 10.62 |
Cash at Beginning of Period | 81.25 | 179.91 | 24.25 | 15.37 | 4.75 |
Cash at End of Period | 40.21 | 81.25 | 179.91 | 24.25 | 15.37 |
Diluted Net EPS | -3.09 | -3.88 | -2.71 | -2.08 | -2.81 |
Fiscal Year End for DermTech, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -20.01 | -100.89 | -81.80 | -62.63 |
Depreciation/Amortization & Depletion | NA | 1.30 | 5.32 | 4.16 | 2.95 |
Net Change from Assets/Liabilities | NA | -1.11 | 0.01 | -2.06 | 2.19 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 2.70 | 18.58 | 15.42 | 12.27 |
Net Cash From Operating Activities | NA | -17.12 | -76.98 | -64.27 | -45.23 |
Property & Equipment | NA | 0.00 | -0.90 | -1.07 | -1.02 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 7.83 | 30.77 | 18.69 | 5.88 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 7.83 | 29.86 | 17.62 | 4.86 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.13 | 6.19 | 6.19 | 5.43 |
Issuance (Repayment) of Debt | NA | 0.00 | -0.11 | -0.09 | -0.06 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 0.12 | 6.08 | 6.10 | 5.38 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -9.16 | -41.04 | -40.55 | -34.99 |
Cash at Beginning of Period | NA | 40.21 | 81.25 | 81.25 | 81.25 |
Cash at End of Period | NA | 31.05 | 40.21 | 40.70 | 46.26 |
Diluted Net EPS | NA | -0.58 | -0.51 | -0.57 | -0.99 |